logo
Select company
Select metric
$ -21.39MNet Cash Flow - Financing
VS
Market
61
Sector
83
Industry
63
History
95
$ 59.44Close
$ 51.75 - $ 68.52 52-Week Range
Ticker Information

Ticker

UTMD

Company Name

UTAH MEDICAL PRODUCTS INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

UTAH MEDICAL PRODUCTS INC - Net Cash Flow - Financing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

UTMD - CF - Financing Historical data
DateNet Cash Flow - Financing
6/30/2025$ -21.39M
3/31/2025$ -24.09M
12/31/2024$ -23.84M
9/30/2024$ -17.16M
6/30/2024$ -13.28M
3/31/2024$ -7.1M
12/31/2023$ -4.17M
9/30/2023$ -4.01M
6/30/2023$ -4.01M
3/31/2023$ -6.55M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • UTAH MEDICAL PRODUCTS INC's latest trailing twelve months (TTM) CF - Financing stands at $ -10.76M.
  • Over the past 5 years, UTAH MEDICAL PRODUCTS INC's average CF - Financing has been $ -10.54M.
  • The median CF - Financing for UTAH MEDICAL PRODUCTS INC during this period was $ -10.34M
  • UTAH MEDICAL PRODUCTS INC reached its highest CF - Financing over the past 5 years at $ -3.78M.
  • The lowest CF - Financing recorded by UTAH MEDICAL PRODUCTS INC in the same timeframe $ -24.09M

UTAH MEDICAL PRODUCTS INC's CF - Financing vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Financing Benchmarks
CompanyCF - Financing
KRMD : KORU MEDICAL SYSTEMS INC $ -194.03KSTXS : STEREOTAXIS INC $ 305KTLSI : TRISALUS LIFE SCIENCES INC $ 39.22MEDIT : EDITAS MEDICINE INC $ 61.49MCCCC : C4 THERAPEUTICS INC $ 10.57MVYGR : VOYAGER THERAPEUTICS INC $ 1.18MTKNO : ALPHA TEKNOVA INC $ 15.2MMXCT : MAXCYTE INC $ 1.18MRVP : RETRACTABLE TECHNOLOGIES INC $ -551.5KPDEX : PRO DEX INC $ -292K

Definition of Net Cash Flow - Financing

[Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.

UTMD - Net Cash Flow - Financing, Last 5 years

$ -24.09M

Minimum

Mar 31, 2025

$ -3.78M

Maximum

Sep 30, 2021

$ -10.54M

Average

$ -10.34M

Median

CF - Financing Benchmark Analysis

The chart above depicts the distribution of CF - Financing for companies in the Total Stock Market. The average CF - Financing of the companies is $ -6.74M with a standard deviation of $ 119.11M.
The following table provides additional summary stats:
CF - Financing in the Market:
filtered constituents3.23K
min$ -367.1M
max$ 366M
average$ -6.74M
median$ 314K
std$ 119.11M